Extremities Chondroitin sulfate superior to celecoxib for cartilage loss reduction in patients with knee OA byJosh SandbergNovember 9, 2015
Hospitals Anika Therapeutics Announces Health Canada Approval of CINGAL® for the Treatment of Pain Associated with Osteoarthritis of the Knee byJosh SandbergNovember 3, 2015
Hospitals FLEXION THERAPEUTICS GRANTED FAST TRACK STATUS BY THE FDA FOR FX006 FOR TREATMENT OF OSTEOARTHRITIS OF THE KNEE byJosh SandbergSeptember 3, 2015
Extremities Top Stories Anika Therapeutics Announces Positive Results from Follow-up Study Evaluating Safety of a Repeat Injection of CINGAL for Treatment of Osteoarthritis of the Knee byJosh SandbergJuly 14, 2015
Extremities Hospitals Anika Therapeutics Files Investigational Device Exemption to Initiate Phase III Study to Expand Indication of MONOVISC® to Treat Pain Caused by Osteoarthritis of the Hip byJosh SandbergJune 23, 2015
Extremities OrthoTrophix Completed Subject Enrollment of the Phase 2 Clinical Trial of a New Cartilage Repair Therapeutic for Knee Osteoarthritis byJosh SandbergMay 22, 2015
Extremities Recon Osteoarthritis patients will benefit from jumping exercise byJosh SandbergFebruary 19, 2015
